Oral cyclosporin formulations

Details Oral cyclosporin formulations Oral cyclosporin formulations

1996-03-21

1998-06-16

Webman, Edward J.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424452, A61K 950, A61K 910, A61K 4734

Patent

active

057666296

ABSTRACT:
Improved oral cyclosporin formulations which have high bioavailability and are capable of administration in hard capsules are provided. In the subject formulations, cyclosporin is delivered in an orally acceptable vehicle comprising at least one alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant. The subject formulations may further comprise at least one cosolvent, where cosolvents of interest include fatty acids and diols. The subject formulations find use in immuno-suppressive therapy.

REFERENCES:
patent: 506219 (1893-04-01), Desai
patent: 4117118 (1978-09-01), Harri et al.
patent: 4220641 (1980-09-01), Traber et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4780316 (1988-10-01), Brox
patent: 4792449 (1988-12-01), Ausman et al.
patent: 4889723 (1989-12-01), Kim et al.
patent: 4970076 (1990-11-01), Horrobin
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5047396 (1991-09-01), Orban et al.
patent: 5051402 (1991-09-01), Kurihara et al.
patent: 5118493 (1992-06-01), Kelley et al.
patent: 5122383 (1992-06-01), Heiber et al.
patent: 5154930 (1992-10-01), Popescu et al.
patent: 5342625 (1994-08-01), Hauer et al.
patent: 5350741 (1994-09-01), Takada
patent: 5364632 (1994-11-01), Benita et al.
patent: 5393791 (1995-02-01), Roberts
patent: 5430017 (1995-07-01), Antalne et al.
patent: 5504068 (1996-04-01), Komiya et al.
patent: 5543393 (1996-08-01), Kim et al.
patent: 5589455 (1996-12-01), Woo
patent: 5614491 (1997-03-01), Walch et al.
Tarr & Yalkowsky, "Enhanced Intestinal Absorption of Cyclosporine in Rats Through the Reduction of Emulsion Droplet Size," Pharmaceutical Research (1989), 6:40-43.
Abdallah and Mayersohn, "The Preparation and Evaluation of a Tablet Dosage Form of Cyclosporine in Dogs, "Pharmaceutical Research (1991), 8:518-522.
Sato et al., "Enhancement of The Intestinal Absorption of Cyclospoine Derivative by Milk Fat Globule Membrane," Biol. Pharm. Bull.17:1526-1528.
Benmoussa et al., "Cyclosporin Absorption Is Impaired by the Fat Substitutes, Sucrose Polyester and Tricarballylate Triester, in the Rat,"Pharmaceutical Research(1994), 11:1458-1461.
Trull et al., "Cyclosporin Absorption From Microemulsion Formulation in Liver Transplant Recipient," The Lancet (1993), 341:433.
Ferrea et al., "Oral Microemulsion Formulation Substitutes for Intravenous Cyclosporin in Child with Graft-Versus-Host Disease," The Lancet (1994), 344:480-481.
Reymond et al., "In Vivo Model for Ciclosporin Intestinal Absorption in Lipid Vehicles," Pharmaceutical Research (1988), 5:677-679.
Ritschel et la., "Improvement of Peroral Absorption of Cyclosporine A By Microemulsions," Meth. Find Exp. Clin. Pharmacol. (1990), 12:127-134.
Reymond and Sucker, "In Vitro Model for Ciclosporin Intestinal Absorption in Lipid Vehicles," Pharmaceutical Research (1988), 5:673-676.
Cavanak and Sucker, "Formulation of Dosage Forms," Prog. Allergy (1986), 38:65-72.

Affiliated with

Also associated with

Rating

Oral cyclosporin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral cyclosporin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral cyclosporin formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1722191